A Retrospective Validations Microsatellite Instability (MSI) Testing v Mismatch Repair (MMR) in Gastric Adenocarcinoma

The Safety and Efficacy of Neoadjuvant Immunochemotherapy Followed by Laparoscopic Gastrectomy for Gastric Cancer

NCT06235164 ·Status: ACTIVE_NOT_RECRUITING

The Relationship Between Microsatellite Instability and Efficacy of Fluorouracil Based Adjuvant Chemotherapy in Gastric Cancer After Operation

NCT03485196 ·Status: COMPLETED

A Randomized Phase II Trial of Neoadjuvant Chemotherapy Compared With Chemoradiotherapy in Gastric Adenocarcinoma

NCT02301481 ·Status: COMPLETED ·Phase: PHASE2

Predictive Biomarkers in Stage II/III Gastric Cancer for Adjuvant Chemotherapy

NCT01905969 ·Status: UNKNOWN

Immune Checkpoint Inhibitors (ICIs) Retreatment in Second-line Treatment of Advanced Gastric Cancer: a Retrospective, Real-world Study

NCT06814548 ·Status: NOT_YET_RECRUITING

Measuring the Negative Predictive Value and Specificity of Serum Biomarkers in Gastric Cancer

NCT06305169 ·Status: NOT_YET_RECRUITING

Pre-operation Chemo and Antibody Therapy Followed by Surgical Resection and Adjuvant Chemoradiation for Gastric Cancer

NCT00857246 ·Status: COMPLETED ·Phase: PHASE2

Tumor Markers Study in Gastric Cancer for Cancer Immunotherapy (ONCO-RD 010 CRT)

NCT02686424 ·Status: SUSPENDED

Real World Study of Immune Checkpoint Inhibitors for Advanced Gastric Cancer

NCT04086888 ·Status: UNKNOWN

The Construction of a Predictive Model for Gastric Cancer Immunotherapy Response Based on Tumor-Infiltrating Lymphocytes (TILs) and Histone H3K4me3 in the Tumor Microenvironment

NCT07069842 ·Status: RECRUITING

Identification of Biomarkers for Prediction of Response or Resistance Against Target Therapy in Gastric Cancer

NCT02305043 ·Status: COMPLETED

Using Genetic Polymorphisms to Predict the Efficacy and Toxicity - A Gastric Adenocarcinoma Study

NCT01558011 ·Status: TERMINATED ·Phase: PHASE2

A Randomized Phase III Study of Adjuvant Chemotherapy With or Without Chemo-radiotherapy in Patients With Local Advanced Gastric Cancer After D2 Resection.

NCT02648841 ·Status: UNKNOWN ·Phase: PHASE3

Compare Different Response Evaluations to Neoadjuvant Chemotherapy for Gastric Cancer

NCT02179463 ·Status: UNKNOWN

Plasma Metabolic Biomarkers for Gastric Cancer Diagnosis

NCT06109805 ·Status: COMPLETED

Multicenter Phase III Trial of Laparoscopic Sentinel Node Biopsy

NCT01804998 ·Status: COMPLETED ·Phase: NA

Prospective Assessment of nProfiler® 1 on Prognosis and Chemotherapy Response for Gastric Cancer

NCT04487717 ·Status: ACTIVE_NOT_RECRUITING

First-Line and Neoadjuvant Immunotherapy for Gastric Cancer

NCT06727981 ·Status: RECRUITING

Prospective Evaluation and Molecular Profiling in People With Gastric Tumors

NCT03027427 ·Status: COMPLETED

Metabolomic and Lipidomic Analysis Predicts Immunotherapy-related Adverse Events in Gastric Cancer Patients

NCT06915389 ·Status: RECRUITING

Improving the Approach to and Management of the Older Patient With Metastatic Gastric Cancer

NCT04618809 ·Status: UNKNOWN ·Phase: NA

Establishment of Serum Proteomics Subtypes of Gastric Cancer and Its Clinical Application

NCT06335576 ·Status: NOT_YET_RECRUITING

Factors Influencing Immunotherapy Response in dMMR/MSI-H Gastric/Gastroesophageal Junction Adenocarcinoma

NCT07259473 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2

Resistance to Immunotherapy in Gastric Cancer

NCT03614013 ·Status: UNKNOWN

The Association Between Microplastics and Macrogenomics and Metabolomics in Gastric Cancer

NCT06856382 ·Status: ACTIVE_NOT_RECRUITING